AML-MSCs at the onset secreted less CSF1 than D-MSCs (Log2FC = −2.79, p = 0.0007), and its secretion remained reduced in remission (Log2FC = −2.71, p = 0.0004). The gene discussed is CSF1; the disease is acute myeloid leukemia.